StudyFinder
Renal Intervention for Chronic Hypertension Pilot Trial Using the Verve Medical RPDT System
Status: Recruiting
The purpose of this study is to test a new treatment approach for adults with high blood pressure that has been difficult to control with medication. Researchers will study how well the treatment helps lower blood pressure and learn more about participants’ experiences with the treatment.
Sex: Male or Female
Age Group: 18 years and over
Inclusion Criteria:
• currently taking 2 medications for high blood pressure and on a stable treatment plan for at least 30 days
• elevated blood pressure despite current treatment
• see link to clinicaltrials.gov for complete inclusion criteria
Exclusion Criteria:
• history of certain heart, kidney, or urinary tract conditions
• pregnant, breastfeeding, or planning to become pregnant during the study
• currently receiving dialysis or prior kidney transplant
• currently enrolled in another hypertension study or previously received device-based treatment for high blood pressure
• see link to clinicaltrials.gov for complete exclusion criteria
Interventions:
Drug: Active hypertension medical therapy, Device: RPD
Conditions:
Heart & Vascular
Keywords:
Clinics and Surgery Center (CSC), Blood pressure, Hypertension, RICH
Study Contact: Kathryn Vera - giero002@umn.edu
Principal Investigator: John Osborn Jr.
Phase: NA
IRB Number: STUDY00024597
See this study on ClinicalTrials.gov